OM
Outset Medical, Inc.$3.97+0.00 (—)Prev Close$4.19·MCap$59.0M·P/E—·Vol—·Yield—
▲
Buys (12M)
1
$870.3K
▼
Sells (12M)
20
$369.2K
◆
Net Activity
Net Buyer
$501.1K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Outset Medical, Inc. (OM) has been dominated by buying, with 1 insider purchase totaling $870.3K and 20 insider sales totaling $369.2K. The most recent insider transaction was by Leonard Braden Michael (10 percent owner), who purchased $870.3K worth of shares on Oct 5, 2026. Outset Medical, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $59.0M.
OM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Leonard Braden Michael | 10 percent owner | Buy | 244,909 | $3.55 | $870.3K1.3% OS | 2,764,610 |
| Aug 18, 2026 | Brottem John L. | officer: General Counsel | Sell | 2,632 | $4.39 | $11.6K | 87,475 |
| Aug 18, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,437 | $4.39 | $15.1K | 194,597 |
| Aug 18, 2026 | Gaeta Renee | officer: Chief Financial Officer | Sell | 4,543 | $4.39 | $19.9K | 180,840 |
| Jun 5, 2026 | Gaeta Renee | officer: Chief Financial Officer | Sell | 17,672 | $4.94 | $87.3K | 113,753 |
| May 19, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 1,582 | $3.70 | $5.9K | 38,393 |
| May 19, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,445 | $3.70 | $12.7K | 98,874 |
| May 19, 2026 | Brottem John L. | officer: General Counsel | Sell | 2,638 | $3.70 | $9.8K | 30,277 |
| Feb 17, 2026 | Brottem John L. | General Counsel | Sell | 2,842 | $3.35 | $9.5K | 0 |
| Feb 17, 2026 | Nash Marc | EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 0 |
| Feb 17, 2026 | Trigg Leslie | Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 0 |
| Jan 21, 2026 | Brottem John L. | officer: General Counsel | Sell | 10,494 | $5.11 | $53.6K | 36,957 |
| Jan 21, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 6,355 | $5.10 | $32.4K | 42,785 |
| Jan 21, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 13,914 | $5.11 | $71.1K | 107,823 |
| Jan 8, 2026 | Brottem John L. | officer: General Counsel | Sell | 224 | $4.27 | $956.48 | 46,271 |
| Jan 8, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 108 | $4.27 | $461.16 | 48,160 |
| Jan 8, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 1,795 | $4.27 | $7.7K | 119,617 |
| Dec 2, 2025 | Drexler Karen | Director | Sell | 1,548 | $4.37 | $6.8K | 10,650 |
| Nov 18, 2025 | Brottem John L. | General Counsel | Sell | 388 | $4.60 | $1.8K | 46,495 |
| Nov 18, 2025 | Nash Marc | EVP Operations R&D & Service | Sell | 247 | $4.60 | $1.1K | 48,268 |
| Nov 18, 2025 | Trigg Leslie | Chair and CEO | Sell | 916 | $4.60 | $4.2K | 121,412 |
| Aug 18, 2025 | Brottem John L. | General Counsel | Sell | 383 | $12.88 | $4.9K | 46,883 |
| Aug 18, 2025 | Nash Marc | SVP Operations and R&D | Sell | 243 | $12.88 | $3.1K | 42,898 |
| Aug 18, 2025 | Trigg Leslie | Chair and CEO | Sell | 904 | $12.88 | $11.6K | 122,328 |
| May 16, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 584 | $17.81 | $10.4K | 16,096 |
| May 16, 2025 | Brottem John L. | General Counsel | Sell | 396 | $17.82 | $7.1K | 11,273 |
| May 16, 2025 | Nash Marc | SVP Operations and R&D | Sell | 252 | $17.82 | $4.5K | 13,465 |
| May 16, 2025 | Trigg Leslie | Chair and CEO | Sell | 935 | $17.80 | $16.6K | 58,129 |
| Feb 19, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 8,659 | $0.90 | $7.8K | 250,210 |
| Feb 19, 2025 | Brottem John L. | General Counsel | Sell | 6,145 | $0.90 | $5.5K | 175,043 |
| Feb 19, 2025 | Nash Marc | SVP Operations and R&D | Sell | 4,204 | $0.90 | $3.8K | 200,764 |
| Feb 19, 2025 | Trigg Leslie | Chair and CEO | Sell | 14,611 | $0.90 | $13.1K | 880,969 |
| Jan 22, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 34,288 | $0.80 | $27.4K | 292,250 |
| Jan 22, 2025 | Brottem John L. | General Counsel | Sell | 32,930 | $0.80 | $26.3K | 213,341 |
| Jan 22, 2025 | Nash Marc | SVP Operations and R&D | Sell | 23,221 | $0.80 | $18.6K | 227,833 |
| Jan 22, 2025 | Trigg Leslie | Chair and CEO | Sell | 65,236 | $0.80 | $52.2K | 956,413 |
| Jan 13, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 29,031 | $0.81 | $23.5K | 279,901 |
| Jan 13, 2025 | Brottem John L. | General Counsel | Sell | 20,492 | $0.81 | $16.6K | 205,028 |
| Jan 13, 2025 | Nash Marc | SVP Operations and R&D | Sell | 15,011 | $0.81 | $12.2K | 222,291 |
| Jan 13, 2025 | Trigg Leslie | Chair and CEO | Sell | 33,227 | $0.81 | $26.9K | 861,397 |
| Jan 7, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 1,835 | $1.29 | $2.4K | 308,932 |
| Jan 7, 2025 | Brottem John L. | General Counsel | Sell | 1,572 | $1.29 | $2.0K | 225,520 |
| Jan 7, 2025 | Nash Marc | SVP Operations and R&D | Sell | 720 | $1.29 | $928.80 | 237,302 |
| Jan 7, 2025 | Trigg Leslie | Chair and CEO | Sell | 10,227 | $1.29 | $13.2K | 894,624 |
| Nov 18, 2024 | Ahmed Nabeel | Chief Financial Officer | Sell | 4,221 | $0.80 | $3.4K | 310,767 |
| Nov 18, 2024 | Brottem John L. | General Counsel | Sell | 3,203 | $0.80 | $2.6K | 227,092 |
| Nov 18, 2024 | Nash Marc | SVP Operations and R&D | Sell | 1,375 | $0.80 | $1.1K | 238,022 |
| Nov 18, 2024 | Trigg Leslie | Chair and CEO | Sell | 5,645 | $0.80 | $4.5K | 904,851 |
| Aug 15, 2024 | Ahmed Nabeel | Chief Financial Officer | Sell | 3,971 | $0.84 | $3.3K | 314,988 |
| Aug 15, 2024 | Brottem John L. | General Counsel | Sell | 3,011 | $0.84 | $2.5K | 230,295 |
Showing 1–50 of 242
1 / 5
OM Insider Buying Activity
The following table shows recent insider purchases of Outset Medical, Inc. (OM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Leonard Braden Michael | 10 percent owner | Buy | 244,909 | $3.55 | $870.3K1.3% OS | 2,764,610 |
OM Insider Selling Activity
The following table shows recent insider sales of Outset Medical, Inc. (OM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Brottem John L. | officer: General Counsel | Sell | 2,632 | $4.39 | $11.6K | 87,475 |
| Aug 18, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,437 | $4.39 | $15.1K | 194,597 |
| Aug 18, 2026 | Gaeta Renee | officer: Chief Financial Officer | Sell | 4,543 | $4.39 | $19.9K | 180,840 |
| Jun 5, 2026 | Gaeta Renee | officer: Chief Financial Officer | Sell | 17,672 | $4.94 | $87.3K | 113,753 |
| May 19, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 1,582 | $3.70 | $5.9K | 38,393 |
| May 19, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,445 | $3.70 | $12.7K | 98,874 |
| May 19, 2026 | Brottem John L. | officer: General Counsel | Sell | 2,638 | $3.70 | $9.8K | 30,277 |
| Feb 17, 2026 | Brottem John L. | General Counsel | Sell | 2,842 | $3.35 | $9.5K | 0 |
| Feb 17, 2026 | Nash Marc | EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 0 |
| Feb 17, 2026 | Trigg Leslie | Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 0 |
| Jan 21, 2026 | Brottem John L. | officer: General Counsel | Sell | 10,494 | $5.11 | $53.6K | 36,957 |
| Jan 21, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 6,355 | $5.10 | $32.4K | 42,785 |
| Jan 21, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 13,914 | $5.11 | $71.1K | 107,823 |
| Jan 8, 2026 | Brottem John L. | officer: General Counsel | Sell | 224 | $4.27 | $956.48 | 46,271 |
| Jan 8, 2026 | Nash Marc | officer: EVP Operations R&D & Service | Sell | 108 | $4.27 | $461.16 | 48,160 |
| Jan 8, 2026 | Trigg Leslie | director, officer: Chair and CEO | Sell | 1,795 | $4.27 | $7.7K | 119,617 |
| Dec 2, 2025 | Drexler Karen | Director | Sell | 1,548 | $4.37 | $6.8K | 10,650 |
| Nov 18, 2025 | Brottem John L. | General Counsel | Sell | 388 | $4.60 | $1.8K | 46,495 |
| Nov 18, 2025 | Nash Marc | EVP Operations R&D & Service | Sell | 247 | $4.60 | $1.1K | 48,268 |
| Nov 18, 2025 | Trigg Leslie | Chair and CEO | Sell | 916 | $4.60 | $4.2K | 121,412 |
| Aug 18, 2025 | Brottem John L. | General Counsel | Sell | 383 | $12.88 | $4.9K | 46,883 |
| Aug 18, 2025 | Nash Marc | SVP Operations and R&D | Sell | 243 | $12.88 | $3.1K | 42,898 |
| Aug 18, 2025 | Trigg Leslie | Chair and CEO | Sell | 904 | $12.88 | $11.6K | 122,328 |
| May 16, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 584 | $17.81 | $10.4K | 16,096 |
| May 16, 2025 | Brottem John L. | General Counsel | Sell | 396 | $17.82 | $7.1K | 11,273 |
| May 16, 2025 | Nash Marc | SVP Operations and R&D | Sell | 252 | $17.82 | $4.5K | 13,465 |
| May 16, 2025 | Trigg Leslie | Chair and CEO | Sell | 935 | $17.80 | $16.6K | 58,129 |
| Feb 19, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 8,659 | $0.90 | $7.8K | 250,210 |
| Feb 19, 2025 | Brottem John L. | General Counsel | Sell | 6,145 | $0.90 | $5.5K | 175,043 |
| Feb 19, 2025 | Nash Marc | SVP Operations and R&D | Sell | 4,204 | $0.90 | $3.8K | 200,764 |
| Feb 19, 2025 | Trigg Leslie | Chair and CEO | Sell | 14,611 | $0.90 | $13.1K | 880,969 |
| Jan 22, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 34,288 | $0.80 | $27.4K | 292,250 |
| Jan 22, 2025 | Brottem John L. | General Counsel | Sell | 32,930 | $0.80 | $26.3K | 213,341 |
| Jan 22, 2025 | Nash Marc | SVP Operations and R&D | Sell | 23,221 | $0.80 | $18.6K | 227,833 |
| Jan 22, 2025 | Trigg Leslie | Chair and CEO | Sell | 65,236 | $0.80 | $52.2K | 956,413 |
| Jan 13, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 29,031 | $0.81 | $23.5K | 279,901 |
| Jan 13, 2025 | Brottem John L. | General Counsel | Sell | 20,492 | $0.81 | $16.6K | 205,028 |
| Jan 13, 2025 | Nash Marc | SVP Operations and R&D | Sell | 15,011 | $0.81 | $12.2K | 222,291 |
| Jan 13, 2025 | Trigg Leslie | Chair and CEO | Sell | 33,227 | $0.81 | $26.9K | 861,397 |
| Jan 7, 2025 | Ahmed Nabeel | Chief Financial Officer | Sell | 1,835 | $1.29 | $2.4K | 308,932 |
| Jan 7, 2025 | Brottem John L. | General Counsel | Sell | 1,572 | $1.29 | $2.0K | 225,520 |
| Jan 7, 2025 | Nash Marc | SVP Operations and R&D | Sell | 720 | $1.29 | $928.80 | 237,302 |
| Jan 7, 2025 | Trigg Leslie | Chair and CEO | Sell | 10,227 | $1.29 | $13.2K | 894,624 |
| Nov 18, 2024 | Ahmed Nabeel | Chief Financial Officer | Sell | 4,221 | $0.80 | $3.4K | 310,767 |
| Nov 18, 2024 | Brottem John L. | General Counsel | Sell | 3,203 | $0.80 | $2.6K | 227,092 |
| Nov 18, 2024 | Nash Marc | SVP Operations and R&D | Sell | 1,375 | $0.80 | $1.1K | 238,022 |
| Nov 18, 2024 | Trigg Leslie | Chair and CEO | Sell | 5,645 | $0.80 | $4.5K | 904,851 |
| Aug 15, 2024 | Ahmed Nabeel | Chief Financial Officer | Sell | 3,971 | $0.84 | $3.3K | 314,988 |
| Aug 15, 2024 | Brottem John L. | General Counsel | Sell | 3,011 | $0.84 | $2.5K | 230,295 |
OM Insiders
Similar Stocks to OM
SYK
Stryker Corporation
$291.40
$117.50B
BSX
Boston Scientific Corporation
$41.87
$66.06B
EW
Edwards Lifesciences Corporation
$92.30
$52.20B
DXCM
DexCom, Inc.
$82.44
$29.67B
ZBH
Zimmer Biomet Holdings, Inc.
$94.63
$18.39B
GKOS
Glaukos Corporation
$237.60
$14.07B
GMED
Globus Medical, Inc.
$78.05
$10.48B
PODD
Insulet Corp.
$149.68
$10.38B